CoChat

Clinical efficacy of nanohydroxyapatite-containing toothpaste at relieving dentin hypersensitivity: an 8 weeks randomized control trial

Open access

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Objective: The objective of this study was to investigate and compare the effectiveness of several toothpastes containing nanohydroxyapatite (nano-HAP) to relieve dentin hypersensitivity (DHS) with that of a commercial desensitizing dentifrice containing calcium sodium phosphosilicate (CSPS). Materials and methods: In this double-blind, randomized, parallel-group clinical trial, patients diagnosed with DHS and qualified to participate were randomized into four groups: toothpaste containing 10% nano-HAP (10%nano-HAP), 15% nano-HAP (15%nano-HAP), 10% nano-HAP supplemented with potassium nitrate (KNO 3 ) (10%nano-HAPKN), or CSPS. Subjects’ baseline and post-treatment sensitivities were assessed using visual analog scale (VAS) after the application of ice-cold and air stimuli. Subjects used their assigned toothpaste for routine toothbrushing twice daily. Post-treatment sensitivity was assessed every 2 or 8 weeks. Mean change in VAS (mm) from baseline at each time point were compared using random-intercept, mixed-model analysis and Duncan test ( P < 0.05). Results: With either air or cold stimulus, VAS indicated a significant ( P < 0.001) reduction from baseline DHS at each time point with all test toothpastes. Among the nano-HAP toothpastes, 15%nano-HAP and 10%nano-HAPKN were consistent in DHS reduction with both stimuli. With either stimuli, the CSPS did not significantly differ from 15%nano-HAP and 10%nano-HAPKN at any time point. Conclusions: Toothpaste containing nano-HAP (10 or 15%) alone or supplemented with KNO 3 was as effective as CSPS for relief of DHS symptoms when used at least twice daily.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41405-021-00080-7

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Patient flow diagram. CSPS calcium sodium phosphosilicate.
Fig. 1 Patient flow diagram. CSPS calcium sodium phosphosilicate.CC BY · PubMed Central
Fig. 2 Reduction in DHS over time measured with VAS after a cold stimulus. For each product, there was a significant (P < 0.001) reduction in DHS at each time point. Comparing the reduction of DHS among the products, the following product pairs differed significantly (P < 0.001) from each other at the indicated measurement time period. Week 2: 10%nano-HAPKN and 10%nano-HAP; week 4: 10%nano-HAPKN and 10%nano-HAP; week 6: 10%nano-HAPKN and 10%nano-HAP, 15%nano-HAP and 10%nano-HAP, CSPS and 10%nano-HAP; and week 8: CSPS and 10%nano-HAP. CSPS calcium sodium phosphosilicate.
Fig. 2 Reduction in DHS over time measured with VAS after a cold stimulus. For each product, there was a significant (P < 0.001) reduction in DHS at each time point. Comparing the reduction of DHS among the products, the following product pairs differed significantly (P < 0.001) from each other at the indicated measurement time period. Week 2: 10%nano-HAPKN and 10%nano-HAP; week 4: 10%nano-HAPKN and 10%nano-HAP; week 6: 10%nano-HAPKN and 10%nano-HAP, 15%nano-HAP and 10%nano-HAP, CSPS and 10%nano-HAP; and week 8: CSPS and 10%nano-HAP. CSPS calcium sodium phosphosilicate.CC BY · PubMed Central
Fig. 3 Reduction in DHS over time measured with VAS after evaporative air stimulus. For each product, there was a significant (P < 0.001) reduction in DHS at each time point. Comparing the reduction of DHS among the products, the following product pairs differed significantly (P < 0.001) from each other at the indicated measurement time period. Week 2: no significant difference among the products. Week 4: 10%nano-HAPKN and 10%nano-HAP; week 6: 10%nano-HAPKN and 10%nano-HAP, 10%nano-HAPKN and 15%nano-HAP; week 8: 10%nano-HAPKN and 10%nano-HAP, CSPS and 10%nano-HAP. CSPS calcium sodium phosphosilicate.
Fig. 3 Reduction in DHS over time measured with VAS after evaporative air stimulus. For each product, there was a significant (P < 0.001) reduction in DHS at each time point. Comparing the reduction of DHS among the products, the following product pairs differed significantly (P < 0.001) from each other at the indicated measurement time period. Week 2: no significant difference among the products. Week 4: 10%nano-HAPKN and 10%nano-HAP; week 6: 10%nano-HAPKN and 10%nano-HAP, 10%nano-HAPKN and 15%nano-HAP; week 8: 10%nano-HAPKN and 10%nano-HAP, CSPS and 10%nano-HAP. CSPS calcium sodium phosphosilicate.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. Kawamata, H., Ohta, K., Saito, T. & Hayman, R. Investigation of dentinal surface coating by nano-hydroxyapatite. J. Dent. Res. 89, 2988 (2010).

Cited by

See all 54

Metadata

Authors
Amaechi, B. T., Lemke, K. C., Saha, S., Luong, M. N., & Gelfond, J.
Affiliations
The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Amaechi, Bennett Tochukwu
Venue
BDJ Open
Published
2021-06-25
Volume
7
Issue
1
Pages
23-23
ISSN
2056-807X (ISSN-L)
OpenAlex
W3173639011
Cited by
48
References
57
Citations by year
2026: 13 · 2025: 10 · 2024: 10 · 2023: 9 · 2022: 5 · 2021: 1
FWCI
6.52
Type
journal article
Language
en
Open access
Licence
Locations
  • BDJ Open (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Sangi Co., Ltd., Japan.
  • Sangi Co., Ltd, Japan
Topics
  • Health Sciences › Dentistry › General Dentistry › Dental Erosion and Treatment
  • Health Sciences › Dentistry › General Dentistry › Dental Health and Care Utilization
  • Health Sciences › Dentistry › Oral Surgery › Endodontics and Root Canal Treatments
Keywords
dentin hypersensitivity, hydroxyapatite nanoparticles, toothpaste, desensitizing dentifrices, calcium sodium phosphosilicate, potassium nitrate, toothbrushing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical efficacy of nanohydroxyapatite-containing toothpaste at relieving dentin hypersensitivity: an 8 weeks randomized control trial. https://app.cochat.ai/papers/10.1038/s41405-021-00080-7
The paper
Amaechi, B. T., Lemke, K. C., Saha, S., Luong, M. N., & Gelfond, J. (2021). Clinical efficacy of nanohydroxyapatite-containing toothpaste at relieving dentin hypersensitivity: an 8 weeks randomized control trial. BDJ Open. https://doi.org/10.1038/s41405-021-00080-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.